« Back to Record
Citation APA

Vathiotis, I. A., Moutafi, M. M., Divakar, P., Aung, T. N., Qing, T., Fernandez, A., Yaghoobi, V., El-abed, S., Wang, Y., Guillaume, S., Nuciforo, P. G., Huober, J., Di Cosimo, S., Kim, S.-B., Harbeck, N., Gomez, H., Shafi, S., Syrigos, K. N., Fountzilas, G., Sotiriou, C., Pusztai, L., Warren, S., & Rimm, D. D. (2021). Alpha-smooth muscle actin expression in the stroma predicts resistance to Trastuzumab in patients with Early-stage HER2-positive breast cancer. Clinical cancer research, 27(22), 6156-6163. doi:10.1158/1078-0432.CCR-21-2103


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/339159

Vathiotis, I. A., Moutafi, M. M., Divakar, P., Aung, T. N., Qing, T., Fernandez, A., Yaghoobi, V., El-abed, S., Wang, Y., Guillaume, S., Nuciforo, P. G., Huober, J., Di Cosimo, S., Kim, S.-B., Harbeck, N., Gomez, H., Shafi, S., Syrigos, K. N., Fountzilas, G., Sotiriou, C., Pusztai, L., Warren, S., & Rimm, D. D. (2021). Alpha-smooth muscle actin expression in the stroma predicts resistance to Trastuzumab in patients with Early-stage HER2-positive breast cancer. Clinical cancer research, 27(22), 6156-6163. doi:10.1158/1078-0432.CCR-21-2103